Update on acute coronary syndromes and ST-elevation myocardial infarction.

Vijay K Verma, Steven M Hollenberg
Author Information
  1. Vijay K Verma: Division of Cardiology, Cooper University Hospital, Robert Wood Johnson Medical School, Camden, New Jersey 08103, USA.

Abstract

PURPOSE: The goal of modern therapy of acute myocardial infarction is twofold: to achieve rapid reperfusion of ischemic myocardium and to decrease subsequent remodeling, which can have deleterious effects on ventricular function and prognosis. The current paradigm for treatment of most patients with acute coronary syndromes is the consideration of an 'early invasive' strategy.
RECENT FINDINGS: Studies published this year have reinforced the importance of early reperfusion, solidified the evidence for early institution of aggressive adjunctive treatment, and added newer therapies to the existing armamentarium. This review evaluates published data from the past year encompassing advancements in percutaneous coronary intervention, drug-eluting stents, glycoprotein IIb/IIIa antagonists, thienopyridines, HMG-CoA reductase inhibitors, aldosterone blockade, low-molecular-weight heparins, direct thrombin inhibitors, implantable cardioverter-defibrillators, and beta-blockade in the treatment of acute coronary syndrome and ST-segment elevation myocardial infarction. In addition to patency of the epicardial coronary arteries, the role of the microvascular has become an area of recent interest.
SUMMARY: As novel modalities and approaches are put to the test of clinical trials, evidence-based therapies may help to lessen the adverse effects of myocardial ischemia and reduce future cardiovascular events.

MeSH Term

Humans
Microcirculation
Myocardial Infarction
Myocardial Ischemia
Myocardial Reperfusion
Risk Assessment
Syndrome
Time Factors
Ventricular Remodeling

Word Cloud

Created with Highcharts 10.0.0coronaryacutemyocardialinfarctiontreatmentreperfusioneffectssyndromespublishedyearearlytherapiesinhibitorsPURPOSE:goalmoderntherapytwofold:achieverapidischemicmyocardiumdecreasesubsequentremodelingcandeleteriousventricularfunctionprognosiscurrentparadigmpatientsconsideration'earlyinvasive'strategyRECENTFINDINGS:Studiesreinforcedimportancesolidifiedevidenceinstitutionaggressiveadjunctiveaddednewerexistingarmamentariumreviewevaluatesdatapastencompassingadvancementspercutaneousinterventiondrug-elutingstentsglycoproteinIIb/IIIaantagoniststhienopyridinesHMG-CoAreductasealdosteroneblockadelow-molecular-weightheparinsdirectthrombinimplantablecardioverter-defibrillatorsbeta-blockadesyndromeST-segmentelevationadditionpatencyepicardialarteriesrolemicrovascularbecomearearecentinterestSUMMARY:novelmodalitiesapproachesputtestclinicaltrialsevidence-basedmayhelplessenadverseischemiareducefuturecardiovasculareventsUpdateST-elevation

Similar Articles

Cited By